Brief Description
ArKal Medical has developed the next generation continuous glucose monitoring system, using its minimally invasive, proprietary and patented MicroTipª technology. The Microtipsª provide painless access to ISF glucose. The ArKal CGM sensor is worn externally on the skin like a patch and measures glucose using classical electrochemical glucose oxidase enzyme-based chemistry. The GlucoPodª CGM system consists of three main components: a disposable sensor patch, a reusable transmitter, and a reusable wireless smart receiver.
Inventors
Dorian Liepmann, Albert Pisano, Boris Stoeber, Stefan Zimmermann